Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Observational Study for ABBV-951 in Patients Diagnosed With Advanced Parkinson's Disease (aPD)

NCT05916157 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05916157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05916157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Observational Study for ABBV-951 in Patients Diagnosed With Advanced Parkinson's Disease (aPD)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Active, not recruiting
Start date
November 30, 2023
Completion date
January 31, 2027
Enrollment
250 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease (pd)